title: Tuberculin skin testing in intravenous drug users: differences between HIV-seropositive and HIV-seronegative subjects.
abstract: The prevalence of tuberculin skin test reactions among intravenous drug abusers and differences in tuberculin skin test positivity between HIV-seropositive and HIV-seronegative subjects were evaluated in a cross-sectional study of 1131 subjects. They were recruited from a therapeutic community, from those who attended the centre for the treatment of drug addiction and from those who visited for any reason an acute tertiary-care hospital in Vitoria-Gasteiz, Basque Country (Spain). All subjects underwent skin testing with purified protein derivative (PPD) tuberculin and testing for HIV antibodies. CD4(+) T-lymphocyte count was determined in HIV-seropositive individuals. Positive PPD tests were recorded in 35% of drug users who were HIV-seropositive and in 65% in those who were HIV-seronegative. In the HIV-infected group, there was a significant association between results of the tuberculin test and CD4(+) T-lymphocyte count. When the CD4(+) T-lymphocyte count was > or = 500 cells/mm(3), percentages of positive PPD tests were similar in HIV-seropositives and HIV-seronegatives (47% versus 65%) but when the CD4(+) count was < 500 cells/mm(3), positive PPD tests occurred in only 21% of HIV-seropositives. The PPD test showed a decreased sensitivity for detecting tuberculosis infection in HIV-infected intravenous drug users with CD4(+) T-lymphocyte counts fewer than 500 cells/mm(3).
authors: Department of Internal Medicine, Hospital Txagorritxu, Vitoria-Gasteiz, Alava, Spain. jportu@htxa.osakidetza.net
authors: José J
authors: JJ
authors: Portu
authors: Mikel
authors: M
authors: Aldamiz-Etxebarria
authors: José M
authors: JM
authors: Agud
authors: José M
authors: JM
authors: Arévalo
authors: María J
authors: MJ
authors: Almaraz
authors: Cándido
authors: C
authors: Ayensa
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000453:epidemiology*; D000293:Adolescent; D000328:Adult; D002648:Child; D015897:Comorbidity; D003430:Cross-Sectional Studies; D005260:Female; D018023:HIV Seronegativity; D006679:HIV Seropositivity / Q000175:diagnosis / Q000453:epidemiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D013030:Spain / Q000453:epidemiology; D015819:Substance Abuse, Intravenous / Q000175:diagnosis / Q000453:epidemiology*; D014374:Tuberculin Test